Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-003200)

Filing Details

Accession Number:: 0001179110-17-003200
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-24 18:19:41
Reporting Period:: 2017-02-22

Filing Date:: 2017-02-24
Accepted Time:: 2017-02-24 18:19:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235010	Momenta Pharmaceuticals Inc	MNTA	Biological Products, (No Disgnostic Substances) (2836)	043561634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1345695	Bruce Leicher	C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-02-22	231	$15.60	176,371	No	4	S	Direct
Common Stock	Disposition	2017-02-22	424	$15.60	175,947	No	4	S	Direct
Common Stock	Disposition	2017-02-22	395	$15.60	175,552	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.